Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-02-25 @ 2:54 AM
Study NCT ID:
NCT02378220
Status:
COMPLETED
Last Update Posted:
2019-09-20
First Post:
2015-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacogenetic Testing Among Home Health Patients
Sponsor:
Genelex Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adverse Drug Events | View |
| None | Adverse Drug Reactions | View |
| None | Drug Interaction Potentiation | View |
| None | Drug Metabolism, Poor, CYP2D6-RELATED | View |
| None | Drug Metabolism, Poor, CYP2C19-RELATED | View |
| None | Cytochrome P450 Enzyme Deficiency | View |
| None | Cytochrome P450 CYP2D6 Enzyme Deficiency | View |
| None | Cytochrome P450 CYP2C9 Enzyme Deficiency | View |
| None | Cytochrome P450 CYP2C19 Enzyme Deficiency | View |
| None | Cytochrome P450 CYP3A Enzyme Deficiency | View |
| None | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | View |
| None | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | View |
| None | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | View |